Personalized treatment is the new cancer frontier. The DNA of a tumor is analyzed, and a specific drug is used to target the mutant gene(s). It's a great concept, but exceedingly expensive to deliver. Or is it?

Cigarette tobacco slowly maims and kills. That message is getting through, unfiltered, loud and clear. The result is that thousands of lives have been saved.

A recent study examined cancer genetics to determine why resistance to Iressa ( gefitinib ), a drug commonly used in treating non small cell lung cancer.

Some types of cancer treatment are on a molecular level, relying on interactions between growth receptor proteins on the cancer cells and drugs that target these specific receptor proteins.

Nothing very appealing about taking whiffs of truck exhaust. The exposure isn't just unappealing, though. It may be deadly.

Fear and anxiety of what lies ahead can be overwhelming for folks who have just learned they have lung cancer. They may not know where to turn for comfort and support, and a nurse might be just who they're looking for.

Chronic  obstructive pulmonary disease ( COPD ) is commonly seen with lung cancer, because both diseases usually result from smoking. Patients who have COPD often have complications after lung cancer surgery.

Determining the best treatment plan for lung cancer is based on a number of factors. New research suggests one form of therapy that doesn't extend life may be overused with older patients.

A common story in cancer treatment is of specialized drugs that work great initially, but over time the cancer becomes resistant to the drug. Finding out why this happens has become paramount for scientists.

Cancer biology overlaps frequently, and some drugs designed for a specific mutation may have multiple uses, as one study shows.